This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Use of CBD Oil in the Treatment of Posttraumatic Stress Disorder

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04197102
Recruitment Status : Suspended (Suspended (The UT IRB determined that CBD oil is being used as a drug as defined by the FDA. Therefore, an IND must be obtained for the use of CBD oil in this research study in accordance with FDA regulations, 21 CFR 312.))
First Posted : December 12, 2019
Last Update Posted : November 22, 2023
Sponsor:
Information provided by (Responsible Party):
Michael J. Telch, University of Texas at Austin

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : May 2025
Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):